Literature DB >> 320608

delta1-tetrahydrocannabinol, cannabidiol and cannabinol effects on the immune response of mice.

S Zimmerman, A M Zimmerman, I L Cameron, H L Laurence.   

Abstract

delta1-tetrahydrocannabinol (THC) elicited a dose-dependent (1, 5, 10 mg/kg) depression of the immune response, of immature mice, stimulated with sheep red blood cells. The impairment of humoral immunity was specific for THC but not for cannabidiol at 25 mg/kg or cannabinol at 25 mg/kg. The mice were given four daily doses (i.p.) of either drug or vehicle (Tween 80-propylene glycol in 1% saline) or a single injection (i.p.) of sheep red blood cells in addition to four daily doses (i.p.) of drug or vehicle. Suppression of the antigenic response by THC was reflected as a reduction of splenic weight, reduction in the number of splenic antibody-forming cells, lowered hemagglutination titer and reduction in the percentage of splenic white pulp of total spleen volume.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 320608     DOI: 10.1159/000136658

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  8 in total

Review 1.  Toward drugs derived from cannabis.

Authors:  R Mechoulam; E A Carlini
Journal:  Naturwissenschaften       Date:  1978-04

2.  The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells.

Authors:  Neta Rimmerman; Ana Juknat; Ewa Kozela; Rivka Levy; Heather B Bradshaw; Zvi Vogel
Journal:  Cell Mol Neurobiol       Date:  2011-04-30       Impact factor: 5.046

3.  Effects of prenatal exposure to delta-9-tetrahydrocannabinol on reproductive, endocrine and immune parameters of male and female rat offspring.

Authors:  L L Murphy; J Gher; A Szary
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

Review 4.  CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Authors:  A Arévalo-Martín; D García-Ovejero; O Gómez; A Rubio-Araiz; B Navarro-Galve; C Guaza; E Molina-Holgado; F Molina-Holgado
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

5.  The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).

Authors:  Barbara L F Kaplan; Alison E B Springs; Norbert E Kaminski
Journal:  Biochem Pharmacol       Date:  2008-07-08       Impact factor: 5.858

6.  The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.

Authors:  Erinn S Raborn; Francine Marciano-Cabral; Nancy E Buckley; Billy R Martin; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2007-07-11       Impact factor: 4.147

Review 7.  AIDS, drugs of abuse and the immune system: a complex immunotoxicological network.

Authors:  R Pillai; B S Nair; R R Watson
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

Review 8.  Immune Responses Regulated by Cannabidiol.

Authors:  James M Nichols; Barbara L F Kaplan
Journal:  Cannabis Cannabinoid Res       Date:  2020-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.